Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Dasheng Biotechnology Company is an OTC-traded company historically focused on bacteria-based products used as additives for livestock feed and crop cultivation in China. Earlier public filings describe a commercial agribiotech business selling artificial microorganisms, high-efficiency microorganism blends, livestock feed additives, and biological preservatives. However, more recent OTC Markets disclosures indicate the issuer has shifted away from biotechnology and describes itself as Cycclone, Inc., an engine design and development company pending a name change. As a result, the historical China Dasheng biotechnology business appears to be the best exact match to the requested name, but the current public issuer associated with the ticker no longer appears to be operating principally as a life science company. Publicly available recent information on any ongoing biotech pipeline is very limited.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Dasheng Biotechnology Company.